South Korea Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update

According to the publisher, South Korea biosimilar market size is expected to record a CAGR of 18.1% during 2023-2027 to reach US$1.171 million by 2027, increasing from US$0.536 billion in 2023. Over the last five years, the sector has recorded a CAGR of 21.2% to reach US$0.442 billion in 2022.

This report provides an in-depth data-centric analysis of the emerging opportunities in the biosimilars industry. It covers a detailed view of market size and forecast across various segments such as by product, type of cell, imaging technique, procedure, source of manufacturing, applications, type of technology, and end users.

This section is a part of the title “Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, and Competitive Landscape - Q2 2023 Update”.

Scope

This report provides an in-depth, data-centric analysis of the South Korea biosimilar market 2018-2027. Below is a summary of key market segments:

Biosimilar Market Size By Product

• Monoclonal Antibody Biosimilars
• Insulin Biosimilar
• Biosimilar Interferons
• Other Biosimilar

Biosimilar Market Size By Type of Cell

• Mammalian
• Non-Mammalian

Biosimilar Market Size By Imaging Technique

• Magnetic Resonance Imaging Scanners
• Computed Tomography Scanners
• Positron Emission Tomography Scanners
• Others

Biosimilar Market Size By Procedure

• Invasive
• Non-Invasive

Biosimilar Market Size By Source of Manufacturing

• In-House
• Contract Manufacturing

Biosimilar Market Size By Applications

• Oncology
• Blood Disorders
• Growth Hormonal Deficiency
• Chronic & Autoimmune Disorders
• Infectious Diseases
• Others

Biosimilar Market Size By Type of Technology

• Mass Spectroscopy
• Chromatography
• Recombinant DNA technology
• Electrophoresis
• Others

Biosimilar Market Size By End User

• Hospital & Clinics
• Diagnostic Centres
• Others

Reasons to buy

• In-depth understanding of biosimilars market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in South Korea.
• Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
• Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals & clinics, diagnostic centres within the South Korea.